Icatibant + Placebo
Phase 3Recruiting 0 views this week 0 watching⚡ Active
Interest: 41/100
41
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Intradialytic Hypotension
Conditions
Intradialytic Hypotension
Trial Timeline
Dec 11, 2023 → Apr 1, 2026
NCT ID
NCT05834777About Icatibant + Placebo
Icatibant + Placebo is a phase 3 stage product being developed by Pharvaris for Intradialytic Hypotension. The current trial status is recruiting. This product is registered under clinical trial identifier NCT05834777. Target conditions include Intradialytic Hypotension.
Hype Score Breakdown
Clinical
17
Activity
15
Company
9
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05834777 | Phase 3 | Recruiting |